PensionDanmark Pensionsforsikringsaktieselskab Buys 7,644 Shares of Cigna Group $CI

PensionDanmark Pensionsforsikringsaktieselskab increased its stake in Cigna Group (NYSE:CIFree Report) by 10.2% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 82,261 shares of the health services provider’s stock after acquiring an additional 7,644 shares during the period. PensionDanmark Pensionsforsikringsaktieselskab’s holdings in Cigna Group were worth $22,678,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Brighton Jones LLC lifted its stake in Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after purchasing an additional 318 shares during the last quarter. Sivia Capital Partners LLC boosted its holdings in shares of Cigna Group by 10.4% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock worth $384,000 after purchasing an additional 109 shares in the last quarter. NewEdge Advisors LLC increased its position in shares of Cigna Group by 4.5% during the 2nd quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock valued at $7,347,000 after purchasing an additional 958 shares during the last quarter. Treasurer of the State of North Carolina raised its holdings in shares of Cigna Group by 16.6% during the 2nd quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock valued at $49,204,000 after buying an additional 21,173 shares in the last quarter. Finally, Osterweis Capital Management Inc. purchased a new position in shares of Cigna Group during the 2nd quarter valued at about $163,000. Institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

Shares of CI stock opened at $275.26 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47. The stock has a 50 day moving average price of $285.90 and a two-hundred day moving average price of $281.20. The company has a market capitalization of $72.73 billion, a P/E ratio of 11.39, a PEG ratio of 0.93 and a beta of 0.29.

Cigna Group (NYSE:CIGet Free Report) last issued its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm had revenue of $70.04 billion for the quarter, compared to analysts’ expectations of $70.14 billion. During the same quarter last year, the business earned $7.20 earnings per share. The business’s revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Analysts expect that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a $1.56 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. Cigna Group’s payout ratio is presently 25.82%.

Analyst Upgrades and Downgrades

CI has been the subject of several research reports. Cantor Fitzgerald upped their target price on Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a research note on Friday, May 1st. Barclays lifted their price target on shares of Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Morgan Stanley boosted their price objective on shares of Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a report on Wednesday, May 20th. Wall Street Zen lowered shares of Cigna Group from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Finally, Guggenheim increased their target price on shares of Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a report on Friday, July 31st. Fifteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat, Cigna Group presently has a consensus rating of “Moderate Buy” and an average target price of $339.45.

Read Our Latest Research Report on Cigna Group

Insider Buying and Selling at Cigna Group

In other news, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO David Cordani sold 201,878 shares of the stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 222,213 shares of company stock worth $64,751,950. 0.60% of the stock is currently owned by company insiders.

Cigna Group Company Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Further Reading

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.